medicalethics

In a recent announcement, Elon Musk's company Neuralink revealed the successful implantation of a brain device in a human, pushing the boundaries of neurotechnology.
 In our latest short, we discuss key considerations for those venturing into such groundbreaking work. 
We emphasize the importance of having a clear investigational plan that outlines study design, methodologies, endpoints, and analysis strategies. 
Additionally, we also highlight the significance of obtaining adequate informed consent to address potential health risks 
The need for meticulous record-keeping for regulatory compliance, including maintaining detailed delegation logs and up-to-date resumes.
These measures are crucial for navigating the complexities of both technological advancements and regulatory policies in this innovative field.

**Sorry! Had to take down this episode and repost it as Mark's voice was somehow muted when Matt exported the file. Fixed now!**

Today Stephen, Mark, and Matt chat about the promising antiviral remdesivir and the ethical dimensions of clinical trials.

Please consider supporting us to help upgrade our equipment and offload our editing responsibilities:

• Give monthly (as little as $5 a month) on our Patreon Page
• Give a one time gift through Venmo at @mattboettger
• Give a one time gift through PayPal here.

Related Articles from Episode:

• A running list of Stephen’s interviews
• Lancet article Mark referenced
• Atlantic article Matt referenced

Want more information on Matt's Living the Real website?
Please click here to sign up for his newsletter and get information when his blog and podcast will launch.